How Peptide
Purity Is
Tested

Two different questions

Analytical testing of a peptide answers two separate questions, and conflating them is a common error.

Purity asks: of everything in this sample, what proportion is a single component? Identity asks: is that component the compound it is claimed to be? A sample can be extremely pure and be the wrong molecule entirely. Purity without identity is not an assurance of anything much.

HPLC: establishing purity

High-performance liquid chromatography works by pushing a dissolved sample through a packed column under high pressure. Different components travel through the column at different rates depending on how strongly they interact with the packing material, so they emerge separated in time. A detector at the far end — usually measuring ultraviolet absorbance — records each component as a peak.

For peptides the usual variant is reversed-phase HPLC (RP-HPLC), where the column packing is non-polar and the mobile phase is a gradient of increasing organic solvent. Peptides separate largely by hydrophobicity.

Purity is then reported as the area of the main peak as a percentage of the total area of all peaks. Impurities in synthetic peptides are typically closely related structures — sequences missing a residue, sequences that terminated early, or products of side reactions during synthesis — which is precisely why they need a separative technique to reveal them.

Mass spectrometry: establishing identity

Mass spectrometry ionises the sample and measures the mass-to-charge ratio of the resulting ions. For a peptide of known sequence, the theoretical mass can be calculated exactly from the constituent amino acids. If the observed mass matches the theoretical mass within instrument tolerance, that is consistent with the sample being the expected compound.

Peptides commonly ionise into multiple charge states, so a spectrum often shows a characteristic series of peaks that resolve to a single molecular weight. A mismatch between observed and theoretical mass is a strong signal that something is wrong — a different compound, an incomplete sequence, or an unexpected modification.

The limits of each technique

Neither technique is a universal answer, and a report should be read with its limits in mind:

• HPLC purity is by peak area at a given detection wavelength. A component that does not absorb at that wavelength may not appear at all.
• HPLC does not distinguish between the target compound and a co-eluting impurity that happens to travel at the same rate.
• Mass spectrometry confirms mass, not sequence order. Two peptides with the same composition in a different order share a mass. Establishing actual sequence requires tandem MS or sequencing.
• Neither technique reports water content, residual solvent or counter-ion content unless those are specifically tested for.

This is why a serious analytical report shows the underlying chromatogram and spectrum rather than just a headline number. The raw trace lets a reader judge peak shape, baseline and the presence of shoulders that a single percentage figure conceals.

Why independent testing matters

A supplier reporting on its own material has an obvious interest in the result. Independent third-party analysis removes that conflict: the laboratory has no stake in the outcome and no relationship with the sale.

Every batch we supply is submitted for independent third-party analysis to verify purity and identity, and the certificate for your batch is available on request. What that certificate does and does not establish is covered in our guide to reading a certificate of analysis.

Frequently Asked Questions

Peptide purity is normally measured by reversed-phase high-performance liquid chromatography (RP-HPLC). The sample is separated into its components as it passes through a column, and each component is recorded as a peak. Purity is reported as the area of the main peak as a percentage of the total area of all peaks.

Mass spectrometry measures the mass-to-charge ratio of the molecule, which is compared against the theoretical mass calculated from the expected amino acid sequence. Agreement within instrument tolerance is consistent with the sample being the expected compound. It confirms mass rather than sequence order.

They answer different questions. HPLC establishes how much of a sample is a single component. Mass spectrometry establishes whether that component is the compound it is claimed to be. A sample can be highly pure and still be the wrong molecule, so purity alone is not sufficient.